Advanced Unresectable

Oncology·MeSH: Neoplasm Metastasis

23 drugs in development·11 companies·1 clinical trial

Drug Pipeline by Phase

Approved(2)

Drug	Company
tukysa	Seagen Inc. (SGEN)
Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco)	Merus N.V. (MRUS)

Phase 3(6)

Drug	Company
Avelumab	Merck & Co., Inc. (MRK)
folinic acid	Merus N.V. (MRUS)
Lartesertib	Merck & Co., Inc. (MRK)
Leucovorin	BeOne Medicines Ltd. (ONC)
Telisotuzumab Adizutecan	AbbVie Inc. (ABBV)
zolbetuximab	Merus N.V. (MRUS)

Phase 2(3)

Drug	Company
leucovorin	BeOne Medicines Ltd. (ONC)
Leucovorin	AbbVie Inc. (ABBV)
Tuvusertib	Merck & Co., Inc. (MRK)

Phase 1(12)

Drug	Company
Budigalimab	AbbVie Inc. (ABBV)
hro761	NOVARTIS AG (NVSEF)
hro761	Novartis AG (NVS)
ST101	PTC THERAPEUTICS, INC. (PTCT)
ST101	Merus N.V. (MRUS)
ST101	Royalty Pharma plc (RPRX)
ST101	Myovant Sciences Ltd. (MYOV)
ST101	Janux Therapeutics, Inc. (JANX)
Temozolomide	Myovant Sciences Ltd. (MYOV)
Temozolomide	Royalty Pharma plc (RPRX)
Temozolomide	Janux Therapeutics, Inc. (JANX)
tislelizumab	BeOne Medicines Ltd. (ONC)

Compare drugs

tukysa vs Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco)tukysa vs Avelumab tukysa vs folinic acid

Frequently asked questions

How many drugs are in development for Advanced Unresectable?

BioSniper tracks 23 drugs in development for Advanced Unresectable across 11 companies.

How many clinical trials target Advanced Unresectable?

There are 1 clinical trial targeting Advanced Unresectable tracked by BioSniper.

Deep-dive into Advanced Unresectable

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis